Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV‑2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The COVID-19 pandemic has resulted in over 168 million cases and 3.4 million deaths to date, while the number of cases continues to r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS infectious diseases 2021-08, Vol.7 (8), p.2337-2351
Hauptverfasser: Biering, Scott B, Van Dis, Erik, Wehri, Eddie, Yamashiro, Livia H, Nguyenla, Xammy, Dugast-Darzacq, Claire, Graham, Thomas G. W, Stroumza, Julien R, Golovkine, Guillaume R, Roberts, Allison W, Fines, Daniel M, Spradlin, Jessica N, Ward, Carl C, Bajaj, Teena, Dovala, Dustin, Schulze-Gamen, Ursula, Bajaj, Ruchika, Fox, Douglas M, Ott, Melanie, Murthy, Niren, Nomura, Daniel K, Schaletzky, Julia, Stanley, Sarah A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!